Related by context. All words. (Click for frequent words.) 81 antibody titers 77 titer 73 antibody titer 69 seroconversion 68 seroprotection 67 antibody responses 67 HI titers 66 hemagglutination inhibition 66 serum concentrations 66 antiviral efficacy 64 μmol L 64 alanine aminotransferase 64 μg ml 64 HIV RNA 64 viremia 63 neutralizing antibody 63 IFN gamma 63 seronegative 63 pg ml 63 serum antibody 63 mcg dose 63 antibody titres 63 HBsAg 63 seropositive 63 aspartate aminotransferase 63 peripheral blood mononuclear 63 nM 63 IgG antibodies 62 PBMCs 62 anti HBs 62 seropositivity 62 IgM 62 serum IgG 62 IgG 62 neutrophil counts 62 alanine aminotransferase ALT 62 virological response 62 mcg mL 62 immunoreactivity 61 serum cortisol 61 leukocyte count 61 microg 61 lymphocyte counts 61 serum ALT 61 HBV DNA 61 IgG antibody 61 HBeAg seroconversion 61 plasma concentrations 61 nanomolar 61 HER2 expression 61 AST ALT 61 Cmax 61 hemoglobin Hb 61 viral titers 61 hemoglobin concentrations 60 neutralizing antibodies 60 NRTI resistance 60 titres 60 lopinavir 60 humoral responses 60 parasitaemia 60 mRNA expression 60 virologic failure 60 undetectable HBV DNA 60 serum creatinine levels 60 tipranavir r 60 homozygotes 60 BALB c mice 60 IgG4 60 seroconverted 60 plasma pharmacokinetics 60 ug mL 60 log# copies mL 60 HCV RNA 60 inhibin 60 mg kg dose 59 platelet reactivity 59 pharmacodynamic PD 59 viraemia 59 IgA 59 ALT elevations 59 nmol liter 59 hemoglobin concentration 59 serum testosterone 59 transaminases 59 serum LDL cholesterol 59 immunological responses 59 NAbs 59 TNF α 59 serum IGF 59 Immune responses 59 lymphocyte count 59 μg mL 59 HCV genotype 59 HIV uninfected 59 definite stent thrombosis 59 lactate dehydrogenase LDH 59 HCV replicon 59 PEG IFN 59 tPSA 59 #OHD levels 59 viral load 59 serum albumin 59 intramuscular dose 59 cTnT 59 pCR 59 tTG 59 eosinophil count 59 transfected cells 59 pertussis toxin 59 immunostaining 58 neutralizing antibody responses 58 alkaline phosphatase 58 pharmacokinetic parameters 58 troponin T 58 virus HBV 58 transgene expression 58 GSTM1 58 serologic 58 GHRH 58 hemagglutination inhibition HAI 58 genotypic resistance 58 apolipoprotein B 58 serum calcium levels 58 PSA nadir 58 reactogenicity 58 plasma glucose 58 lactate dehydrogenase 58 interferon γ 58 seroprotective 58 ritonavir boosted 58 serum PTH 58 serum TSH 58 daunorubicin 58 virologic 58 virologic response 58 interleukin IL -6 58 caspofungin 58 transaminase levels 58 cTnI 58 antigen PSA levels 58 NNRTI resistance 58 enteroviral 58 CIN3 58 mIU ml 58 antigenicity 58 PASI scores 58 NPH insulin 58 fosamprenavir 58 mIU mL 58 IFN alpha 58 hsCRP levels 58 IFN beta 58 lymphocytosis 58 highly immunogenic 58 plasma HCV RNA 58 creatinine ratio 58 creatinine levels 58 Gag Pol 58 serum homocysteine 58 serum urate 58 dose cohort 58 neutrophil count 58 specific antigen PSA 58 abacavir lamivudine 57 CsA 57 K#R [002] 57 imatinib therapy 57 serum antibodies 57 ertapenem 57 heterozygotes 57 plasma leptin 57 transaminase elevations 57 μg kg 57 HbA 1c levels 57 SCr 57 NOAEL 57 lumbar spine BMD 57 sUA 57 clusterin 57 PCV2 57 immunogenicity 57 inhibitory concentration 57 log# 57 hours postdose 57 effector function 57 CC genotype 57 thyroid stimulating hormone 57 tHcy 57 posaconazole 57 leukocytosis 57 plasma cortisol 57 granulocyte 57 TNFalpha 57 homocysteine concentrations 57 viral loads 57 PSADT 57 adiponectin concentrations 57 elevated ALT 57 euthyroid 57 log# reduction 57 transfected 57 piperacillin tazobactam 57 ALT normalization 57 dose dependently 57 CD4 + CD# 57 SGPT 57 certolizumab 57 ovalbumin 57 hemagglutination 57 Neisseria gonorrhoeae 57 resected pancreatic cancer 57 Pharmacokinetics PK 57 vWF 57 expressors 57 VZV 57 mcg BID 57 CD# upregulation 57 interferon alfa 2b 57 serum potassium 57 replicon 57 IGFBP 57 serum prostate 57 p# antigen 57 serum HBV DNA 57 Hb A1C 57 amprenavir 57 mg/m2 dose 57 HCV genotypes 57 pg mL 57 aminotransferase levels 57 albumin excretion 57 Ad5 57 cells mcL 57 viral titer 57 NNRTI resistant virus 57 rheumatoid factor 57 heterozygous 57 Neutrophil 57 serum testosterone levels 57 alpha1 57 Viral load 57 serum PSA 57 baseline LDH 57 REYATAZ r arm 57 methicillin sensitive 57 DLTs 57 supernatants 56 leptin concentrations 56 RBC folate 56 nmol L 56 IFN α 56 thyroglobulin 56 specific IgE 56 IgM antibodies 56 elevated creatinine 56 plasma folate 56 aPTT 56 nucleotide analog 56 ELISPOT 56 micafungin 56 plasma triglycerides 56 liver histology 56 virologic responses 56 seroprevalence 56 progression TTP 56 Replikin Count 56 pharmacokinetics PK 56 iodixanol 56 uM 56 hematologic toxicity 56 K ras mutations 56 EDSS score 56 isoprostane 56 S. aureus isolates 56 Hb 56 CR nPR 56 penetrance 56 immunoglobulin G 56 HBeAg 56 serum calcium 56 baseline HbA1c 56 antiviral activity 56 serum phosphate levels 56 TIMP 56 TT genotype 56 serum uric acid 56 CMV infection 56 rhGH 56 % CI #.#-#.# [003] 56 pyrazinamide 56 HBV DNA levels 56 BRSV 56 MIC# [001] 56 IU ml 56 anti Xa 56 adiponectin levels 56 alveolar epithelial cells 56 viral kinetics 56 #β estradiol 56 -#.# log# copies mL 56 p = #.# [003] 56 mutated KRAS 56 #ng/ml 56 virologically 56 Clusterin 56 genotype 1a 56 % Confidence Interval 56 alpha defensins 56 antisera 56 chlamydial 56 serum ferritin 56 ALT elevation 56 blood glucose concentrations 56 CANCIDAS 56 capsular polysaccharide 56 platelet counts 56 bronchoalveolar lavage 56 HepG2 cells 56 ACR# responses 56 HER2 amplification 56 -#.# log# 56 complete cytogenetic response 56 adefovir 56 atazanavir ritonavir 56 univariate analysis 56 hypophosphatemia 56 CD8 responses 56 indinavir 56 EpCAM 56 CCyR 56 HOMA IR 56 IU mL 56 μg L 56 thyrotropin 56 dose cyclophosphamide 56 iPTH 56 #mg BID [003] 56 Immunohistochemical analysis 56 cART 56 pegIFN 56 Replikin Count TM 56 CD4 + cell 56 estrogen receptor ER 56 endogenous EPO 56 Telbivudine 56 triacylglycerol concentrations 56 PCR assay 55 HPV-#/# 55 gemcitabine carboplatin 55 PaO 2 55 adalimumab 55 tumorigenicity 55 fasting insulin 55 lowest tertile 55 methicillin resistant MRSA 55 pmol L 55 serum IgE 55 enterococcal 55 dose regimen 55 paricalcitol 55 QbG# 55 aspartate aminotransferase AST 55 MBq 55 HRIG 55 bezafibrate 55 lymph node metastasis 55 pharmacokinetic PK profile 55 baseline CD4 55 triglyceride concentrations 55 severe rotavirus gastroenteritis 55 vivo potency 55 cytokeratin 55 serum HCV RNA 55 atazanavir 55 K#N 55 administered subcutaneously 55 hepatoma 55 % CI #.#-#.# [007] 55 inhibitory concentrations 55 dose ritonavir 55 HIV HCV coinfected 55 serum urate levels 55 hepatocellular carcinomas 55 fluvastatin 55 receptor binding 55 isoenzyme 55 nmol 55 erythrocyte 55 virologic suppression 55 relapsed MM 55 vaccinia 55 atheroma volume 55 virus subtype 55 S/GSK# 55 macroalbuminuria 55 μg 55 MADRS score 55 μM 55 MF# adjuvanted 55 chlorambucil 55 detectable HCV RNA 55 μg dose 55 NT proBNP concentrations 55 serologically 55 immunoblotting 55 #mg dose [001] 55 p = .# [002] 55 nelfinavir 55 dose cohorts 55 Ki# 55 lymphopenia 55 CFU ml 55 antigen 55 pulmonary arterial 55 anemia hemoglobin 55 inhibin B 55 pretest probability 55 4CMenB 55 dose cytarabine 55 nephrotoxicity 55 inactivated vaccine 55 Vacc 4x 55 lispro 55 #OHD 55 plasma renin activity 55 PCa 55 #mg/m# [002] 55 eosinophilia 55 external genital lesions 55 median CD4 55 leukocyte counts 55 activated partial thromboplastin 55 lopinavir r 55 coinfected 55 dexamethasone Decadron 55 M. bovis 55 HLA antigens 55 intramuscularly 55 d dimer 55 pharmacodynamic profile 55 low expressors 55 CD#c 55 adjuvanted 55 #.#mg/dL 55 coinfection 55 teriflunomide 55 IgE antibodies 55 fetuin 55 HGPIN 55 urine albumin 55 isotypes 55 hMG 55 baseline FEV 55 bioavailable testosterone 55 globulin 55 microsomal 55 PegIFN RBV 55 response CCyR 55 CD4 counts 55 BARACLUDE ® 55 #.#/#.# mm Hg [003] 55 Fig. 3b 55 Platelet counts 55 pT3 55 rizatriptan 55 urate levels 55 posttreatment 55 hepatic enzymes 55 TRAIL R2 55 S aureus 55 multivariable analysis 55 immunologically 55 antibiotic susceptibility 55 IgG1 55 extensive metabolizers 55 TMC# r 55 Engerix B 55 CIN2 + 55 inflammatory biomarkers 54 glycemia 54 genotype 1b 54 dosage regimens 54 ng dL 54 LPV r 54 8mg/kg 54 VCAM 1 54 transferrin saturation 54 grade cervical intraepithelial 54 ^ sup #m 54 postprandial glycemia 54 inhibitory activity 54 procollagen 54 ELISpot 54 peginterferon alfa 2a #KD 54 advanced adenomas 54 HLA DR 54 serum vitamin D 54 experienced virologic failure 54 virulence genes 54 monoclonal 54 neutropaenia 54 corticosterone levels 54 potent antiretroviral therapy 54 tirofiban 54 cathepsin B 54 tissue transglutaminase 54 immunized mice 54 biochemical relapse 54 sensitivity specificity 54 timepoints 54 Kinoid 54 creatine phosphokinase 54 antiretroviral naive 54 serum aminotransferase levels 54 LEXIVA r 54 sulfasalazine 54 AZT zidovudine Retrovir 54 sustained virological response 54 HCV viral 54 cellularity 54 CD4 + 54 FOLPI 54 KRAS mutations 54 triacylglycerol 54 mg TID 54 #ug [001] 54 viremic 54 antibodies 54 P = .# 54 urinary albumin 54 MAGE A3 54 HLA B 54 IgE antibody 54 fluticasone salmeterol 54 gastric adenocarcinoma 54 ASCUS 54 endometrial thickness 54 serum retinol 54 insulin detemir 54 follicle stimulating hormone FSH 54 low dose ritonavir 54 circulating IGF 54 airway hyperresponsiveness 54 CLL cells 54 #mg/kg [002] 54 urinary iodine 54 RSV hospitalizations 54 db db mice 54 ACTH 54 cells μL 54 BRCA2 mutation carriers 54 oestradiol 54 IFN γ 54 atopy 54 CK # plasma concentrations 54 microsomes 54 Her2/neu 54 mesalamine granules 54 thyroid carcinoma 54 TOP2A 54 cardiac troponin T 54 HSCT 54 saline placebo 54 undetectable viral 54 fructosamine 54 ovarian carcinoma 54 CD4 lymphocyte count 54 parasitemia 54 serum phosphate 54 maternal antibodies 54 wildtype 54 complete cytogenetic 54 FDG uptake 54 5alpha reductase 54 rhTSH 54 nicardipine 54 myeloperoxidase 54 CD8 T cell 54 serum folate 54 highest tertile 54 live attenuated influenza 54 albumin excretion rate 54 aluminum hydroxide adjuvant 54 ml kg 54 Decitabine 54 cytotoxicity 54 tyrosine phosphorylation 54 intact parathyroid hormone 54 D Dimer 54 reticulocyte 54 erythrocyte sedimentation rate 54 Th2 cytokines 54 rs# [001] 54 C. albicans 54 MMSE score 54 T2DM 54 S. enterica 54 mg RDEA# 54 viral suppression 54 umol L 54 antibody 54 syngeneic 54 TIMP 1 54 mmol l 54 allele frequencies 54 extracapsular extension 54 elevated LDH 54 L. monocytogenes 54 BCG vaccinated 54 infectivity 54 diastolic BP 54 #μg [002] 54 lamivudine 54 monovalent 54 enfuvirtide 54 suppressive therapy 54 LAIV 54 HbF 54 EpCAM expression 54 imipenem 54 fasting plasma glucose FPG 54 recurrent VTE 54 mL/min/#.# m 2 54 postvaccination 54 LEXIVA 54 Genotypes 54 genotypic 54 HBeAg positive patients 54 Gag polymorphisms 54 IL 1ß 54 HLA DRB1 * 54 CR CRu 54 tryptase 54 colorectal liver metastases 54 H. influenzae 54 IgA deficiency 54 macrolide antibiotic 54 FEV ^ sub 54 interleukin IL -# 54 intraperitoneal injection 54 ApoB 54 Ad5 vector 54 Valortim R 54 cytopathic 54 VLPs 54 SHBG levels 54 M#V mutation 54 glycated hemoglobin levels 54 N. gonorrhoeae 54 Fig. 2A 54 paraprotein 54 DAS# remission 54 concentration Cmax 54 fig. S2 54 paraoxonase 54 glucocorticoid 54 leukopenia 54 ACh 54 immunocompetent 54 antitumor efficacy 54 HbA1c levels 54 S. aureus 54 phosphorylated tau 54 Bcl xL 54 vaccinees 54 prevalences 54 Hematologic toxicity 54 M2e 54 cholera toxin 54 Peg IFN 54 OGTT 54 gametocytes 54 urinary oxalate 54 antiviral potency 54 tumor perfusion 54 folate concentrations 53 μg dL 53 interferon IFN 53 clostridial 53 isotype 53 triiodothyronine 53 HBV vaccine 53 IGFBP 3 53 Supplementary Fig 53 ug kg 53 C#BL 6 mice 53 MnSOD 53 immunogenic 53 Gram stain 53 C. trachomatis 53 immune responses 53 dose dexamethasone 53 mcg kg 53 EBRT 53 cervical intraepithelial neoplasia 53 iNOS 53 IL#B 53 ritonavir boosted protease inhibitor 53 HER2/neu 53 nmol L. 53 sustained virologic response 53 bactericidal activity 53 interferon beta 53 serum clusterin levels 53 advanced adenoma 53 Elitek 53 systemic absorption 53 HIV coinfected 53 serum bilirubin 53 dose limiting toxicities 53 proteinuria 53 murine 53 glycosylated hemoglobin levels 53 rapid virological response 53 bronchial epithelial cells 53 cEVR 53 intima media thickness 53 ABC/3TC 53 adenoma recurrence 53 biodistribution 53 pDCs 53 cynomolgus monkeys 53 acromegalic patients 53 heterodimers 53 CD# expression [001] 53 TDF FTC 53 microvessel density 53 #mg/m# [001] 53 antithymocyte globulin 53 plasma renin 53 β blockers 53 ‰ ¥ 53 B7 H3 53 null mice 53 serum lipid levels 53 serum creatinine 53 tuberculin skin testing 53 HuR 53 steroid dexamethasone 53 fasting glucose levels 53 MetS 53 SGOT 53 pneumococci 53 recurrent genital herpes 53 pharmacodynamics 53 lopinavir r arm 53 systemic toxicity 53 aminotransferase 53 ug ml 53 glomerular filtration rate 53 decitabine 53 LNCaP cells 53 EGFRvIII 53 fluoroquinolone resistance 53 virological failure 53 amoxicillin clavulanate 53 hydroxyvitamin D levels 53 glomerular filtration 53 ascending doses 53 hematological parameters 53 ERBB2 53 S. Typhimurium 53 Virologic 53 missense mutations 53 antiandrogens 53 receiving VICTRELIS 53 apoA 53 alkaline phosphatase ALP 53 IV bisphosphonates 53 preoperative PSA 53 thyroid hormone levels 53 Aptivus ® 53 transgenic rats 53 ferritin 53 Response Evaluation Criteria 53 severe neutropenia 53 Pharmacokinetic parameters 53 GABHS 53 serogroup 53 survivin 53 VEGF expression 53 Capecitabine 53 epithelial tumors 53 #.#ng/ml 53 receptor blocker 53 serum phosphorus 53 nanomolar range 53 maternal serum 53 HBeAg negative patients 53 alpha2 53 lupus anticoagulant 53 #mmHg [001] 53 plasma glucose levels 53 Immunoglobulin 53 S. suis 53 protective antigen 53 surface antigen HBsAg 53 bilirubin levels 53 AUC0 53 deacetylation 53 urine NGAL 53 ESBLs 53 cortisol concentrations 53 Toxicities 53 palivizumab 53 H#N# viruses 53 urinary N telopeptide 53 SUVmax 53 autoantibody levels 53 BCG vaccination 53 CLA supplementation 53 sUA levels 53 de novo synthesis 53 inhibitor RG# 53 JAK2 V#F 53 D dimer 53 airway responsiveness 53 CrCl 53 plasma lipid 53 bovine thrombin 53 IL 1beta 53 Enterobacter cloacae 53 CpG 53 genotype 53 RASSF1A 53 antiretroviral naïve 53 mg BID 53 attain statistical significance 53 cells uL 53 ionophore 53 DAS# scores 53 dose clopidogrel 53 biochemical recurrence 53 Baseline characteristics 53 homodimers 53 p# activation 53 bioactivity 53 ribavirin RBV 53 LDL cholesterol concentrations 53 downregulated 53 μg liter 53 YKL 53 TUNEL 53 Natalizumab 53 trastuzumab 53 tumor histology 53 im peramivir 53 glucuronide 53 urinary calcium 53 odds ratios ORs 53 induces antibodies 53 allele frequency 53 tumor antigen 53 quinolone resistant 53 antitumor effect 53 del 5q 53 heparanase 53 leucopenia 53 CIN2 53 GH deficiency 53 imatinib 53 independent prognostic marker 53 grade cervical dysplasia 53 peginterferon alfa 2b 53 virologic breakthrough 53 HCV antibody 53 mcg doses 53 interferon gamma 53 serum BDNF 53 undetectable viral load 53 TNFa 53 Hb levels 53 fluconazole resistant 53 rFSH 53 pneumococcal infection 53 Kaplan Meier analysis 53 #μg [001] 53 urinary cortisol 53 cefotaxime 53 inducible nitric oxide synthase 53 demyelinating 53 NOD SCID mice 53 p = NS 53 pulmonary artery pressure 53 CD3 + 53 genotypes 53 peak plasma concentrations 53 endoglin 53 KRAS mutant tumors 53 copies mL 53 chi squared 53 Telintra 53 CK MB 53 mU L 53 antigenically 53 gp# [001] 53 hypogonadal 53 innate immune responses 53 evaluable subjects 53 moderate renal impairment 53 heterologous 53 peptide antigens 53 hA# 53 defensin 53 rapid virologic response 53 HBeAg positive 53 gastric carcinoma 53 busulfan 53 P selectin 53 nitrotyrosine 53 plasma uric acid 53 splenocytes 53 CagA 53 alfa 2a 53 UGT#A# * 53 mg m² 53 hTERT 53 antiviral prophylaxis 53 Myelosuppression 53 serovar 53 ERK activation 53 MenACWY CRM 53 radezolid 53 heterozygote 53 tertile 53 IFNg 53 biotinylated 53 -#.# ± [002] 53 follicular fluid 53 pegylated interferon alfa 2a 53 leukotriene 53 systemic bioavailability 53 Tolerability 53 RANTES 53 aminotransferases 53 ribavirin therapy 52 carotid IMT 52 Flu Cy 52 APTIVUS 52 HBeAg + 52 TURBT 52 gliadin 52 Infectivity 52 hydroxychloroquine 52 valine 52 NRTI backbone 52 plasma viremia 52 assay detects 52 ara C 52 cidofovir 52 thyroid peroxidase 52 metabolite concentrations 52 serotonin synthesis 52 immunodeficient 52 CD8 + 52 FasL 52 HOXB# 52 detemir 52 LDL particle 52 E. faecium 52 rifamycins 52 ß = 52 pharmacokinetic profile 52 allelic variants 52 glycosylated hemoglobin HbA1c 52 4mg/kg 52 serum estradiol 52 NY ESO 52 Kruskal Wallis test 52 autoantibody 52 cobicistat 52 % CI #.#-#.# [006] 52 nucleoside analog 52 GSTT1 52 tuberculin skin test 52 solithromycin 52 sFlt 1 52 orthologs 52 CI -#.# 52 mice lacking 52 C. perfringens 52 urinary excretion 52 azilsartan medoxomil 52 undetectable viral loads 52 CTAP# Capsules 52 liver transplant recipients 52 systolic BP 52 tertiles 52 circulating lymphocytes 52 CORE OM 52 liposomal amphotericin B 52 inflammatory markers 52 oxacillin 52 trivalent inactivated influenza 52 sitosterol 52 ceftriaxone 52 SIV infection 52 platelet aggregation